Suppr超能文献

慢性阻塞性肺疾病和间质性肺疾病患者作为肺移植候选者时的肺动脉壁疾病

Pulmonary arterial wall disease in COPD and interstitial lung diseases candidates for lung transplantation.

作者信息

Domingo Enric, Grignola Juan C, Aguilar Rio, Messeguer Manuel López, Roman Antonio

机构信息

Area del Cor, Hospital Universitari Vall d'Hebron, Barcelona, Spain.

Physiology Department, School of Medicine, Universitat Autonoma, Barcelona, Spain.

出版信息

Respir Res. 2017 May 6;18(1):85. doi: 10.1186/s12931-017-0568-z.

Abstract

BACKGROUND

Pulmonary hypertension (PH) associated with lung disease has the worst prognosis of all types of PH. Pulmonary arterial vasculopathy is an early event in the natural history of chronic obstructive pulmonary disease (COPD) and interstitial lung disease (ILD). The present study characterized the alterations in the structure and function of the pulmonary arterial (PA) wall of COPD and ILD candidates for lung transplantation (LTx).

METHODS

A cohort of 73 patients, 63 pre-LTx (30 COPD, 33 ILD), and ten controls underwent simultaneous right heart catheterisation and intravascular ultrasound (IVUS). Total pulmonary resistance (TPR), capacitance (Cp), and the TPR-Cp relationship were assessed. PA stiffness and the relative area of wall thickness were estimated as pulse PA pressure/IVUS pulsatility and as [(external sectional area-intimal area)/external sectional area] × 100, respectively.

RESULTS

Twenty-seven percent of patients had pulmonary arterial wedge pressure > 15 mmHg and were not analyzed. PA stiffness and the area of wall thickness were increased in comparison with controls, even in patients without PH (p < 0.05). ILD patients showed a significant higher PA stiffness, and lower Cp beyond mean PA pressure (mPAP) and lower area of wall thickness than COPD patients (p < 0.05). TPR-Cp relationship was shifted downward left for ILD patients.

CONCLUSIONS

Significant increase of PA stiffness and area of wall thickness were present even in patients without PH and can make the diagnosis of pulmonary vasculopathy at a preclinical stage in PH-lung disease candidates for LTx. ILD patients showed the worst PA stiffness and Cp with respect to COPD.

摘要

背景

与肺部疾病相关的肺动脉高压(PH)在所有类型的PH中预后最差。肺动脉血管病变是慢性阻塞性肺疾病(COPD)和间质性肺疾病(ILD)自然病程中的早期事件。本研究对COPD和ILD肺移植(LTx)候选者的肺动脉(PA)壁结构和功能的改变进行了特征描述。

方法

73例患者组成的队列,其中63例为LTx术前患者(30例COPD,33例ILD),10例为对照,同时接受右心导管检查和血管内超声(IVUS)检查。评估总肺阻力(TPR)、电容(Cp)以及TPR-Cp关系。PA僵硬度和相对壁厚面积分别通过肺动脉搏动压/IVUS搏动性以及[(外截面积-内膜面积)/外截面积]×100来估算。

结果

27%的患者肺动脉楔压>15 mmHg,未纳入分析。与对照组相比,即使是无PH的患者,PA僵硬度和壁厚面积也增加(p<0.05)。ILD患者的PA僵硬度显著更高,平均肺动脉压(mPAP)以上的Cp更低,壁厚面积比COPD患者更低(p<0.05)。ILD患者的TPR-Cp关系向左下方偏移。

结论

即使是无PH的患者,PA僵硬度和壁厚面积也显著增加,这可在LTx的PH-肺部疾病候选者的临床前期诊断出肺血管病变。相对于COPD,ILD患者的PA僵硬度和Cp最差。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/18ac/5420403/2974d32a8949/12931_2017_568_Fig1_HTML.jpg

相似文献

3
Pulmonary hypertension in chronic obstructive pulmonary disease and interstitial lung diseases.
Semin Respir Crit Care Med. 2009 Aug;30(4):458-70. doi: 10.1055/s-0029-1233315. Epub 2009 Jul 24.
5
Pulmonary hypertension in chronic obstructive and interstitial lung diseases.
Int J Cardiol. 2013 Oct 3;168(3):1795-804. doi: 10.1016/j.ijcard.2013.06.033. Epub 2013 Jul 11.
6
CT evaluation of small pulmonary vessels area in patients with COPD with severe pulmonary hypertension.
Thorax. 2016 Sep;71(9):830-7. doi: 10.1136/thoraxjnl-2015-207696. Epub 2016 Apr 15.
7
[Pulmonary hypertension in COPD and interstitial lung diseases].
Dtsch Med Wochenschr. 2009 Aug;134 Suppl 5:S164-6. doi: 10.1055/s-0029-1225315. Epub 2009 Aug 28.
9
Right ventricular dysfunction and remodeling in chronic obstructive pulmonary disease without pulmonary hypertension.
J Am Coll Cardiol. 2013 Sep 17;62(12):1103-1111. doi: 10.1016/j.jacc.2013.04.091. Epub 2013 Jul 10.
10
Secondary Pulmonary Hypertension Among Patients Qualified for Lung Transplantation: Single-Center Study.
Transplant Proc. 2020 Sep;52(7):2101-2109. doi: 10.1016/j.transproceed.2020.02.120. Epub 2020 Apr 24.

引用本文的文献

1
Pulmonary vascular pressure respiratory swings in COPD and ILD candidates for lung transplantation: Large but different.
Pulm Circ. 2024 Mar 6;14(1):e12348. doi: 10.1002/pul2.12348. eCollection 2024 Jan.
3
Strategizing Drug Therapies in Pulmonary Hypertension for Improved Outcomes.
Pharmaceuticals (Basel). 2022 Oct 10;15(10):1242. doi: 10.3390/ph15101242.
4
Emerging phenotypes of pulmonary hypertension associated with COPD: a field guide.
Curr Opin Pulm Med. 2022 Sep 1;28(5):343-351. doi: 10.1097/MCP.0000000000000890. Epub 2022 Jul 16.
6
Association Between Systemic and Pulmonary Vascular Dysfunction in COPD.
Int J Chron Obstruct Pulmon Dis. 2020 Aug 26;15:2037-2047. doi: 10.2147/COPD.S257679. eCollection 2020.

本文引用的文献

1
Pulmonary Hypertension in Diffuse Parenchymal Lung Diseases.
Chest. 2017 Jan;151(1):204-214. doi: 10.1016/j.chest.2016.08.002. Epub 2016 Aug 20.
2
Age-related upper limits of normal for maximum upright exercise pulmonary haemodynamics.
Eur Respir J. 2016 Apr;47(4):1179-88. doi: 10.1183/13993003.01307-2015. Epub 2015 Dec 17.
3
Right heart catheterisation: best practice and pitfalls in pulmonary hypertension.
Eur Respir Rev. 2015 Dec;24(138):642-52. doi: 10.1183/16000617.0062-2015.
7
Pulmonary hypertension in idiopathic pulmonary fibrosis with mild-to-moderate restriction.
Eur Respir J. 2015 Nov;46(5):1370-7. doi: 10.1183/13993003.01537-2014. Epub 2015 Aug 6.
8
Pulmonary hemodynamic profile in chronic obstructive pulmonary disease.
Int J Chron Obstruct Pulmon Dis. 2015 Jul 14;10:1313-20. doi: 10.2147/COPD.S78180. eCollection 2015.
10
The role of pulmonary arterial stiffness in COPD.
Respir Med. 2015 Nov;109(11):1381-90. doi: 10.1016/j.rmed.2015.06.005. Epub 2015 Jun 12.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验